Literature DB >> 30626701

Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.

Mark F Mehler1,2,3,4,5,6,7,8,9,10, Jenna R Petronglo1,2,3,6, Eduardo E Arteaga-Bracho1,2,4,6, Maria E Gulinello4,6, Michael L Winchester1,2,3,6, Nandini Pichamoorthy1,2,3,6, Stephen K Young1,2,3,6, Christopher D DeJesus1,2,4,6, Hifza Ishtiaq1,2, Solen Gokhan1,2,3,6, Aldrin E Molero11,2,3,6.   

Abstract

Emerging studies are providing compelling evidence that the pathogenesis of Huntington's disease (HD), a neurodegenerative disorder with frequent midlife onset, encompasses developmental components. Moreover, our previous studies using a hypomorphic model targeting huntingtin during the neurodevelopmental period indicated that loss-of-function mechanisms account for this pathogenic developmental component (Arteaga-Bracho et al., 2016). In the present study, we specifically ascertained the roles of subpallial lineage species in eliciting the previously observed HD-like phenotypes. Accordingly, we used the Cre-loxP system to conditionally ablate the murine huntingtin gene (Httflx) in cells expressing the subpallial patterning markers Gsx2 (Gsx2-Cre) or Nkx2.1 (Nkx2.1-Cre) in Httflx mice of both sexes. These genetic manipulations elicited anxiety-like behaviors, hyperkinetic locomotion, age-dependent motor deficits, and weight loss in both Httflx;Gsx2-Cre and Httflx;Nkx2.1-Cre mice. In addition, these strains displayed unique but complementary spatial patterns of basal ganglia degeneration that are strikingly reminiscent of those seen in human cases of HD. Furthermore, we observed early deficits of somatostatin-positive and Reelin-positive interneurons in both Htt subpallial null strains, as well as early increases of cholinergic interneurons, Foxp2+ arkypallidal neurons, and incipient deficits with age-dependent loss of parvalbumin-positive neurons in Httflx;Nkx2.1-Cre mice. Overall, our findings indicate that selective loss-of-huntingtin function in subpallial lineages differentially disrupts the number, complement, and survival of forebrain interneurons and globus pallidus GABAergic neurons, thereby leading to the development of key neurological hallmarks of HD during adult life. Our findings have important implications for the establishment and deployment of neural circuitries and the integrity of network reserve in health and disease.SIGNIFICANCE STATEMENT Huntington's disease (HD) is a progressive degenerative disorder caused by aberrant trinucleotide expansion in the huntingtin gene. Mechanistically, this mutation involves both loss- and gain-of-function mechanisms affecting a broad array of cellular and molecular processes. Although huntingtin is widely expressed during adult life, the mutant protein only causes the demise of selective neuronal subtypes. The mechanisms accounting for this differential vulnerability remain elusive. In this study, we have demonstrated that loss-of-huntingtin function in subpallial lineages not only differentially disrupts distinct interneuron species early in life, but also leads to a pattern of neurological deficits that are reminiscent of HD. This work suggests that early disruption of selective neuronal subtypes may account for the profiles of enhanced regional cellular vulnerability to death in HD.
Copyright © 2019 the authors 0270-6474/19/391893-18$15.00/0.

Entities:  

Keywords:  cell vulnerability; development; interneurons; neurodegeneration; pathogenesis; subpallium

Mesh:

Substances:

Year:  2019        PMID: 30626701      PMCID: PMC6407290          DOI: 10.1523/JNEUROSCI.2443-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  101 in total

1.  Quantitative neuropathological changes in presymptomatic Huntington's disease.

Authors:  E Gómez-Tortosa; M E MacDonald; J C Friend; S A Taylor; L J Weiler; L A Cupples; J Srinidhi; J F Gusella; E D Bird; J P Vonsattel; R H Myers
Journal:  Ann Neurol       Date:  2001-01       Impact factor: 10.422

Review 2.  Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias.

Authors:  M J West
Journal:  Trends Neurosci       Date:  1999-02       Impact factor: 13.837

3.  Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR.

Authors:  Michael W Pfaffl; Graham W Horgan; Leo Dempfle
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

4.  Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice.

Authors:  Shenfeng Qiu; Kimberly M Korwek; Adeola R Pratt-Davis; Melinda Peters; Mica Yael Bergman; Edwin J Weeber
Journal:  Neurobiol Learn Mem       Date:  2005-12-20       Impact factor: 2.877

5.  Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse.

Authors:  W S Liu; C Pesold; M A Rodriguez; G Carboni; J Auta; P Lacor; J Larson; B G Condie; A Guidotti; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

6.  White matter volume and cognitive dysfunction in early Huntington's disease.

Authors:  Leigh J Beglinger; Peg C Nopoulos; Ricardo E Jorge; Douglas R Langbehn; Ania E Mikos; David J Moser; Kevin Duff; Robert G Robinson; Jane S Paulsen
Journal:  Cogn Behav Neurol       Date:  2005-06       Impact factor: 1.600

7.  Preclinical Huntington's disease: compensatory brain responses during learning.

Authors:  Andrew Feigin; Maria-Felice Ghilardi; Chaorui Huang; Yilong Ma; Maren Carbon; Mark Guttman; Jane S Paulsen; Claude P Ghez; David Eidelberg
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

8.  Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.

Authors:  Tara L Spires; Helen E Grote; Sylvia Garry; Patricia M Cordery; Anton Van Dellen; Colin Blakemore; Anthony J Hannan
Journal:  Eur J Neurosci       Date:  2004-05       Impact factor: 3.386

9.  Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.

Authors:  J Kassubek; F D Juengling; T Kioschies; K Henkel; J Karitzky; B Kramer; D Ecker; J Andrich; C Saft; P Kraus; A J Aschoff; A C Ludolph; G B Landwehrmeyer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

Review 10.  Normal huntingtin function: an alternative approach to Huntington's disease.

Authors:  Elena Cattaneo; Chiara Zuccato; Marzia Tartari
Journal:  Nat Rev Neurosci       Date:  2005-12       Impact factor: 34.870

View more
  14 in total

Review 1.  Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observations.

Authors:  Carlos Cepeda; Katerina D Oikonomou; Damian Cummings; Joshua Barry; Vannah-Wila Yazon; Dickson T Chen; Janelle Asai; Christopher K Williams; Harry V Vinters
Journal:  J Neurosci Res       Date:  2019-07-28       Impact factor: 4.164

2.  Allele-Specific Knockdown of Mutant Huntingtin Protein via Editing at Coding Region Single Nucleotide Polymorphism Heterozygosities.

Authors:  Sarah R Oikemus; Edith L Pfister; Ellen Sapp; Kathryn O Chase; Lori A Kennington; Edward Hudgens; Rachael Miller; Lihua Julie Zhu; Akanksh Chaudhary; Eric O Mick; Miguel Sena-Esteves; Scot A Wolfe; Marian DiFiglia; Neil Aronin; Michael H Brodsky
Journal:  Hum Gene Ther       Date:  2022-01       Impact factor: 5.695

Review 3.  Neurogenetic disorders across the lifespan: from aberrant development to degeneration.

Authors:  Richard A Hickman; Sarah A O'Shea; Mark F Mehler; Wendy K Chung
Journal:  Nat Rev Neurol       Date:  2022-01-05       Impact factor: 42.937

4.  Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Authors:  Carlos Cepeda; Michael S Levine
Journal:  Neuroscientist       Date:  2020-11-16       Impact factor: 7.235

5.  Subarachnoid Hemorrhage Induces Sub-acute and Early Chronic Impairment in Learning and Memory in Mice.

Authors:  E V Golanov; G W Britz; A S Regnier-Golanov; M Gulinello; M S Hernandez
Journal:  Transl Stroke Res       Date:  2022-03-08       Impact factor: 6.800

6.  Abnormal brain development in child and adolescent carriers of mutant huntingtin.

Authors:  Ellen van der Plas; Douglas R Langbehn; Amy L Conrad; Timothy R Koscik; Alexander Tereshchenko; Eric A Epping; Vincent A Magnotta; Peggy C Nopoulos
Journal:  Neurology       Date:  2019-08-01       Impact factor: 9.910

7.  Striatal Projection Neurons Require Huntingtin for Synaptic Connectivity and Survival.

Authors:  Caley J Burrus; Spencer U McKinstry; Namsoo Kim; M Ilcim Ozlu; Aditya V Santoki; Francia Y Fang; Annie Ma; Yonca B Karadeniz; Atesh K Worthington; Ioannis Dragatsis; Scott Zeitlin; Henry H Yin; Cagla Eroglu
Journal:  Cell Rep       Date:  2020-01-21       Impact factor: 9.423

8.  MRI-guided histology of TDP-43 knock-in mice implicates parvalbumin interneuron loss, impaired neurogenesis and aberrant neurodevelopment in amyotrophic lateral sclerosis-frontotemporal dementia.

Authors:  Ziqiang Lin; Eugene Kim; Mohi Ahmed; Gang Han; Camilla Simmons; Yushi Redhead; Jack Bartlett; Luis Emiliano Pena Altamira; Isobel Callaghan; Matthew A White; Nisha Singh; Stephen Sawiak; Tara Spires-Jones; Anthony C Vernon; Michael P Coleman; Jeremy Green; Christopher Henstridge; Jeffrey S Davies; Diana Cash; Jemeen Sreedharan
Journal:  Brain Commun       Date:  2021-05-27

Review 9.  The Neurodevelopmental Hypothesis of Huntington's Disease.

Authors:  Ellen van der Plas; Jordan L Schultz; Peg C Nopoulos
Journal:  J Huntingtons Dis       Date:  2020

10.  Abnormal Brain Development in Huntington' Disease Is Recapitulated in the zQ175 Knock-In Mouse Model.

Authors:  Chuangchuang Zhang; Qian Wu; Hongshuai Liu; Liam Cheng; Zhipeng Hou; Susumu Mori; Jun Hua; Christopher A Ross; Jiangyang Zhang; Peggy C Nopoulos; Wenzhen Duan
Journal:  Cereb Cortex Commun       Date:  2020-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.